Assessment of safety in repeat dosing of an in vivo topical gene therapy for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) in a phase I/II trial Marinkovich, M., Forte, S., Oliver, S., Dolorito, J., Sridhar, K., Liu, H., Reitze, N., Sarma, N., Krishnan, S. ELSEVIER SCIENCE INC. 2021: S28

View details for Web of Science ID 000641872800155